Sangamo Therapeutics Inc (NASDAQ: SGMO) is 68.42% higher on its value in year-to-date trading and has touched a low of $0.29 and a high of $1.48 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SGMO stock was last observed hovering at around $0.96 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $0.92, the stock is 9.94% and 17.87% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.93 million and changing -4.71% at the moment leaves the stock 42.96% off its SMA200. SGMO registered 12.88% gain for a year compared to 6-month gain of 30.16%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 6.42% loss in the last 1 month and extending the period to 3 months gives it a 94.76%, and is 9.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.96% over the week and 10.16% over the month.
Sangamo Therapeutics Inc (SGMO) has around 405 employees, a market worth around $190.52M and $12.28M in sales. Profit margin for the company is -2033.69%. Distance from 52-week low is 214.32% and -38.18% from its 52-week high. The company has generated returns on investments over the last 12 months (-472.99%).
The EPS is expected to grow by 68.83% this year.
Sangamo Therapeutics Inc (SGMO) Top Institutional Holders
158.0 institutions hold shares in Sangamo Therapeutics Inc (SGMO), with institutional investors hold 43.10% of the company’s shares. The shares outstanding are 208.22M, and float is at 198.84M with Short Float at 9.03%. Institutions hold 42.11% of the Float.
The top institutional shareholder in the company is WASATCH ADVISORS LP with over 20.09 million shares valued at $7.2 million. The investor’s holdings represent 11.1403% of the SGMO Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 14.06 million shares valued at $5.04 million to account for 7.7963 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.9 million shares representing 6.5977% and valued at over $4.26 million, while BLACKROCK INC. holds 2.6078 of the shares totaling 4.7 million with a market value of $1.69 million.
Sangamo Therapeutics Inc (SGMO) Insider Activity
The most recent transaction is an insider sale by BIOGEN INC., the company’s 10% Owner. SEC filings show that BIOGEN INC. sold 6,000,000 shares of the company’s common stock on Sep 26 ’23 at a price of $0.50 per share for a total of $3.0 million. Following the sale, the insider now owns 17.65 million shares.
